Allied Biotech (ROCO:1780) Long-Term Debt: NT$29.9 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1780 Allied Biotech Corp ROCO:1780
73 GF Score
Price NT$23.75
GF Value NT$21.30
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Allied Biotech Long-Term Debt?

Allied Biotech ROCO:1780 +1.28% 73 Long-Term Debt is NT$29.9 Mil as of Mar. 2026. GuruFocus rates ROCO:1780 with a GF Score™ of 73/100 and a GF Value™ of NT$21.30 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Allied Biotech's Long-Term Debt for the quarter that ended in Mar. 2026 was NT$29.9 Mil.

Allied Biotech's quarterly Long-Term Debt declined from Sep. 2025 (NT$39.0 Mil) to Dec. 2025 (NT$34.5 Mil) and declined from Dec. 2025 (NT$34.5 Mil) to Mar. 2026 (NT$29.9 Mil).

Allied Biotech's annual Long-Term Debt declined from Dec. 2023 (NT$71.1 Mil) to Dec. 2024 (NT$52.8 Mil) and declined from Dec. 2024 (NT$52.8 Mil) to Dec. 2025 (NT$34.5 Mil).

Allied Biotech  (ROCO:1780) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Allied Biotech Long-Term Debt Related Terms

Allied Biotech Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Allied Biotech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allied Biotech Long-Term Debt Chart

Allied Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 89.38 71.07 52.76 34.46

Allied Biotech Quarterly Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.19 43.61 39.03 34.46 29.88
ROCO:1780
73GF Score
Allied Biotech Corp ROCO:1780
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of NT$29.9 Mil mean?
Allied Biotech (ROCO:1780) has a Long-Term Debt of NT$29.9 Mil as of Mar. 2026.
Is Allied Biotech's Long-Term Debt too high?
Allied Biotech's current Long-Term Debt is NT$29.9 Mil. Overall, Allied Biotech has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Allied Biotech's Long-Term Debt compare to ZTS?
Allied Biotech's Long-Term Debt of NT$29.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Allied Biotech's current Long-Term Debt is NT$29.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allied Biotech stock overvalued right now?
Based on GuruFocus' analysis, Allied Biotech (ROCO:1780) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$21.30, compared to a current price of NT$23.75 — trading 11.5% above its estimated fair value. The current Long-Term Debt is NT$29.9 Mil. Allied Biotech's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Allied Biotech (ROCO:1780), the current Long-Term Debt is NT$29.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Allied Biotech (ROCO:1780) Overvalued in 2026?

Based on GuruFocus' analysis, Allied Biotech stock appears to be overvalued. The current stock price of NT$23.75 is trading 11.5% above its estimated GF Value™ of NT$21.30. GuruFocus considers Allied Biotech to be Modestly Overvalued.

Key valuation signals for ROCO:1780:

  • Long-Term Debt: NT$29.9 Mil
  • GF Value™: NT$21.30 vs. price of NT$23.75 (11.5% above fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the ROCO:1780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Allied Biotech Business Description

Address No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.
73GF Score

Get the complete analysis for ROCO:1780

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$23.75
Price
NT$21.30
GF Value